| NO |
NAME |
DATE |
| 1 | Osimertinib resistance mechanisms in non-small cell lung cancer using focused CRISPRScreen: FOSL1 an... | 08/07/2023 - 12/07/2023 |
| 2 | A molecular portrait of retinoids and EZH2 inhibitors cooperation to orchestrate cytotoxic effects o... | 08/07/2023 - 12/07/2023 |
| 3 | AkciÄŸer Kanserinde Cisplatin Direncinde Etkili Genetik
Faktörlerin Tüm Genom CRISPR/CAS9-tabanlı... | 16/03/2023 - 18/03/2023 |
| 4 | The Molecular Role of RUVBL1 Gene on Cancer Cell Phenotypes in Malignant Pleural Mesothelioma... | 26/10/2022 - 30/10/2022 |
| 5 | ATG9A Gene is Required for the Survival of Malignant Pleural Mesothelioma Cells... | 26/10/2022 - 30/10/2022 |
| 6 | Investigating Partners in Crime: Osimertinib Resistance Mechanisms in Non-small Cell Lung Cancer Usi... | 06/08/2022 - 09/08/2022 |
| 7 | Genome-wide CRISPR screen identifies BUB1 as a cancer-dependency gene in malignantpleural mesothelio... | 09/07/2022 - 14/07/2022 |
| 8 | AXL is essential for survival of mesenchymal-like HCC cells... | 09/06/2022 - 12/06/2022 |
| 9 | The Role of Autophagy on Differentiation of Corneal Endothelial Cells from hiPSCs... | 09/06/2022 - 12/06/2022 |
| 10 | Targeted delivery of CRISPR/Cas9 plasmid system for cancer immunotherapy approaches... | 28/03/2022 - 31/03/2022 |
| 11 | CRISPR-Cas9 Teknolojisi ile in vitro F8 Geninin Fonksiyonunun Bozulmasının Sağlanması... | 18/02/2022 - 20/02/2022 |
| 12 | Küçük Hücreli Dışı Akciğer Kanserinde Genetik Olmayan Osimertinib Direnç Mekanizmalarının... | 28/10/2021 - 31/10/2021 |
| 13 | Generation of R132H point mutation by CRISPR/Cas9 method in colon cancer cell line... | 16/09/2021 - 18/09/2021 |
| 14 | Generation of cell models using CRISPR/Cas9-based gene therapy to study molecular functions of IDH i... | 09/09/2021 - 11/09/2021 |
| 15 | Revealing the Role of Retinoids On the Phenotypic and Epigenetic Landscape of Bladder Cancer Cells... | 10/04/2021 - 11/04/2021 |
| 16 | Identification of Essential Genes in Malignant Pleural Mesothelioma Using Genome-Wide CRISPR/Cas9-Ba... | 28/01/2021 - 31/01/2021 |
| 17 | Gen Düzeltme ve CRISPR... | 15/10/2020 - 18/10/2020 |
| 18 | A Novel Concept for Immune Checkpoint Gene Knockout Via Lipid Based Non-Viral Delivery Systems... | 05/03/2020 - 07/03/2020 |
| 19 | Genom Düzenlemede Genç Araştırmacılar İçin Fırsatlar... | 05/03/2020 - 07/03/2020 |
| 20 | CRISPR-Cas9 Genom Düzenleme... | 26/02/2020 - 28/02/2020 |
| 21 | Hepatoselüler karsinom hücre hatlarında Malt1 tükenmesinin büyüme baskılayıcı etkilerinin a... | 14/11/2019 - 17/11/2019 |
| 22 | HEPATOSELÜLER KARSİNOMADA YENİ YAKLAŞIM: POTANSİYEL İLAÇ HEDEFİ OLARAK AXL RESEPTÖRÜ... | 14/11/2019 - 17/11/2019 |
| 23 | Hepatoselüler karsinomda TGF-ß yanıtının hücresel mekanizmalarının araştırılması... | 14/11/2019 - 17/11/2019 |
| 24 | İnvaziv olan ve invaziv olmayan mesane kanseri hücre hatlarını karakterize eden transkripsiyonel... | 14/11/2019 - 17/11/2019 |
| 25 | TGF-beta'ya bağlı kanser hücre sekretomunun regülasyonunda Malt1'ın rolü... | 14/11/2019 - 17/11/2019 |
| 26 | Malign plevral mezotelyoma tümörigenez mekanizmalarının CRISPR-Cas9 tarama ile araştırılması... | 14/11/2019 - 17/11/2019 |
| 27 | Genome-wide CRISPR-Cas9 Screening for Identification of Cancer Essential Genes in Malign Pleural Mes... | 27/10/2019 - 31/10/2019 |
| 28 | Hepatoselüler karsinomda AXL'ın rolü... | 27/10/2019 - 30/10/2019 |
| 29 | Identification of transcriptional regulatory networks characterizing invasive and non-invasive bladd... | 03/10/2019 - 05/10/2019 |
| 30 | Malt1 Paracaspase Inhibition Reduces Hepatocellular Carcinoma Cell Survival... | 18/09/2019 - 22/09/2019 |
| 31 | Kanser Esansiyel Genlerin Tüm Genom CRISPR-Cas9 Taramalarla Araştırılması... | 18/10/2018 - 21/10/2018 |
| 32 | The Role of Malt1 Paracaspase in Hepatocellular Carcinoma... | 05/09/2018 - 08/09/2018 |
| 33 | Investigation of the Cellular Mechanisms of TGF-beta-induced Senescence-Resistance in Hepatocellular... | 05/09/2018 - 08/09/2018 |
| 34 | AXL as a Potential Target in Liver Cancer... | 05/09/2018 - 08/09/2018 |
| 35 | Systematic Comparison of Constitutive Promoters in Chinese Hamster Ovary Cells... | 05/09/2018 - 08/09/2018 |
| 36 | Engineering and Functional Validation of Clonal Cell Lines with Stable Cas9 Expression for Genome-Wi... | 05/09/2018 - 08/09/2018 |
| 37 | The New Frontier of Genome Engineering: The CRISPR-Cas9 System
... | 24/05/2018 - 27/05/2018 |
| 38 | Genom Mühendisliği ve CRISPR-Cas Devrimi... | 10/05/2018 - 13/05/2018 |
| 39 | TÄ°YOREDOKSÄ°N ETKÄ°LEŞİMLÄ° PROTEÄ°N HGF/C-MET YOLAÄžININ BÄ°R HEDEFÄ°DÄ°R VE AGRESÄ°F FENOTÄ°P Ä... | 23/02/2018 - 25/02/2018 |
| 40 | Biomarkers and CRISPR... | 10/05/2017 - 12/05/2017 |
| 41 | CRISPR-Cas9 Ä°ÅŸlevsel Genomik Tarama ve Rekabet Tayini ile Kanser Esansiyel Genlerin KeÅŸfi ve Ä°n ... | 10/02/2017 - 12/02/2017 |
| 42 | Truncating Alleles in TP53 Produce Separation of Function Mutants That Actively Promote Tumorigenesi... | 01/06/2016 - 05/06/2016 |
| 43 | In Vitro and In Vivo Characterization Of Cell Survival Genes Using Destabilized Cas9... | 04/05/2016 - 07/05/2016 |
| 44 | A rapid and tunable method to temporally control Cas9 expression enables the characterization of ess... | 24/09/2015 - 27/09/2015 |
| 45 | Does Akt inactivation promote metastasis of PTEN mutant cancer?... | 12/05/2015 - 16/05/2015 |
| 46 | Functional characterization of genomic abnormalities that cooperate with EGFR and K-Ras oncogenic mu... | 11/05/2015 - 12/05/2015 |
| 47 | Myc drives Pten/p53-deficient proliferation and metastasis due to Il6-secretion and Akt-suppression ... | 18/04/2015 - 22/04/2015 |
| 48 | p53psi is a neomorphic p53 isoform that reprograms cells towards the acquisition of metastatic featu... | 14/08/2012 - 18/08/2012 |
| 49 | SOCS2 leads to EGFR TKi resistance in lung cancer by activating IL-6 mediated signaling... | 14/08/2012 - 18/08/2012 |
| 50 | Substrate specifity of receptor tyrosine kinases is critical for selective signaling... | 14/08/2012 - 18/08/2012 |
| 51 | TGF-beta signalling is functional, but its senescence response is defective in poorly differentiated... | 30/10/2009 - 03/11/2009 |
| 52 | The Effects of Telomerase Inhibitor GRN163L (Imetelstat) On Cell Cytoskeleton and Cell Cycle... | 28/10/2009 - 31/10/2009 |
| 53 | Effect of Akt pathway inhibitors in HCC: a novel target for treatment... | 03/09/2009 - 06/09/2009 |
| 54 | The Effects of Telomerase Inhibitor "GRN163L" on Different Cell Lines... | 11/07/2009 - 16/07/2009 |
| 55 | Downregulation and the anti-growth effect of Zeb2 in hepatocellular carcinoma... | 21/05/2009 - 24/05/2009 |
| 56 | TGF-beta induces senescence in epithelial-like hepatocellular carcinoma cells... | 21/05/2009 - 24/05/2009 |
| 57 | Molecular Mechanisms of TGF-beta-induced senescence in hepatocellular carcinoma... | 29/10/2008 - 01/11/2008 |
| 58 | TGF-beta induces p53/Rb-independent, but oxidative stress-dependent cellular senescence in hepatocel... | 05/10/2007 - 07/10/2007 |
| 59 | SMAD interacting protein 1 (SIP-1) acts as a negative regulator of growth in hepatocellular carcinom... | 05/10/2007 - 07/10/2007 |
| 60 | Role of SMAD interacting protein 1 in reprogramming of replicative senescence... | 24/03/2007 - 26/03/2007 |
| 61 | Role of TGF-beta and ROS signaling pathways in hepatocellular senescence... | 24/03/2007 - 26/03/2007 |
| 62 | Role of TGF-beta signaling in hepatocellular senescence... | 24/06/2006 - 29/06/2009 |
| 63 | Induction of replicative senescence in hepatocellular carcinoma cells... | 24/06/2006 - 29/06/2006 |
